Sfoglia per Autore
Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel?
2016-01-01 DEL RE, Marzia; Citi, Valentina; Crucitta, Stefania; Rofi, Eleonora; Belcari, Francesca; Van Schaik, R. H.; Danesi, Romano
KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA.
2016-01-01 DEL RE, Marzia; Bordi, Paola; Citi, Valentina; Crucitta, Stefania; Rofi, Eleonora; Petrini, Iacopo; Tiseo, Marcello; Danesi, Romano
Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase.
2017-01-01 Del Re, M; Restante, G; Di Paolo, A; Crucitta, S; Rofi, E; Danesi, R.
The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients
2017-01-01 DEL RE, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano
The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide
2017-01-01 DEL RE, Marzia; Fogli, Stefano; Derosa, Lisa; Massari, Francesco; De Souza, Paul; Crucitta, Stefania; Bracarda, Sergio; Santini, Daniele; Danesi, Romano
Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680â7
2018-01-01 Del Re, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano
Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment
2018-01-01 Arrigoni, Elena; Del Re, Marzia; Galimberti, Sara; Restante, Giuliana; Rofi, Eleonora; Crucitta, Stefania; Baratè, Claudia; Petrini, Mario; Danesi, Romano; Di Paolo, Antonello
Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells
2018-01-01 Del Re, Marzia; Arrigoni, Elena; Restante, Giuliana; Passaro, Antonio; Rofi, Eleonora; Crucitta, Stefania; De Marinis, Filippo; Di Paolo, Antonello; Danesi, Romano
PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
2018-01-01 DEL RE, Marzia; Marconcini, Riccardo; Pasquini, Giulia; Rofi, Eleonora; Vivaldi, Caterina; Bloise, Francesco; Restante, Giuliana; Arrigoni, Elena; Caparello, Chiara; Bianco, MARIA GRAZIA; Crucitta, Stefania; Petrini, Iacopo; Vasile, Enrico; Falcone, Alfredo; Danesi, Romano
EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance
2018-01-01 Fogli, Stefano; Polini, Beatrice; DEL RE, Marzia; Petrini, Iacopo; Passaro, Antonio; Crucitta, Stefania; Rofi, Eleonora; Danesi, Romano
Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment
2018-01-01 Del Re, Marzia; Crucitta, Stefania; Restante, Giuliana; Rofi, Eleonora; Arrigoni, Elena; Biasco, Elisa; Sbrana, Andrea; Coppi, Erika; Galli, Luca; Bracarda, Sergio; Santini, Daniele; Danesi, Romano
The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response
2018-01-01 Del Re, Marzia; Bordi, Paola; Rofi, Eleonora; Restante, Giuliana; Valleggi, Simona; Minari, Roberta; Crucitta, Stefania; Arrigoni, Elena; Chella, Antonio; Morganti, Riccardo; Tiseo, Marcello; Petrini, Iacopo; Danesi, Romano
Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients
2019-01-01 Del Re, Marzia; Bertolini, Ilaria; Crucitta, Stefania; Fontanelli, Lorenzo; Rofi, Eleonora; DE ANGELIS, Claudia; Diodati, Lucrezia; Cavallero, Diletta; Gianfilippo, Giulia; Salvadori, Barbara; Fogli, Stefano; Falcone, Alfredo; Scatena, Cristian; Naccarato, Antonio Giuseppe; Roncella, Manuela; Ghilli, Matteo; Morganti, Riccardo; Fontana, Andrea; Danesi, Romano
Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy
2019-01-01 Del Re, Marzia; Crucitta, Stefania; Gianfilippo, Giulia; Passaro, Antonio; Petrini, Iacopo; Restante, Giuliana; Michelucci, Angela; Fogli, Stefano; de Marinis, Filippo; Porta, Camillo; Chella, Antonio; Danesi, Romano
From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC
2019-01-01 Bordi, Paola; Del Re, Marzia; Minari, Roberta; Rofi, Eleonora; Buti, Sebastiano; Restante, Giuliana; Squadrilli, Anna; Crucitta, Stefania; Casartelli, Chiara; Gnetti, Letizia; Azzoni, Cinzia; Bottarelli, Lorena; Petrini, Iacopo; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Danesi, Romano; Tiseo, Marcello
Circulating biomarkers of response to immunotherapy in cancer treatment
2019-01-01 Re, M. D.; Gianfilippo, G.; Crucitta, S.; Addeo, A.; Van Schaik, R. H. N.; Danesi, R.
AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer
2019-01-01 Del Re, Marzia; Crucitta, Stefania; Sbrana, Andrea; Rofi, Eleonora; Paolieri, Federico; Gianfilippo, Giulia; Galli, Luca; Falcone, Alfredo; Morganti, Riccardo; Porta, Camillo; Efstathiou, Eleni; van Schaik, Ron; Jenster, Guido; Danesi, Romano
Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy
2019-01-01 Crucitta, S.; Restante, G.; Del Re, M.; Bertolini, I.; Bona, E.; Rofi, E.; Fontanelli, L.; Gianfilippo, G.; Fogli, S.; Stasi, I.; Ghilli, M.; Fontana, A.; Danesi, R.
Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers
2019-01-01 Rofi, E.; Del Re, M.; Arrigoni, E.; Rizzo, M.; Fontanelli, L.; Crucitta, S.; Gianfilippo, G.; Restante, G.; Fogli, S.; Porta, C.; Danesi, R.; Schmidinger, M.
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring
2019-01-01 Pasqualetti, Francesco; Restante, Giuliana; Gonnelli, Alessandra; Rofi, Eleonora; Molinari, Alessandro; Crucitta, Stefania; Paiar, Fabiola; Rudà, Roberta; Danesi, Romano; Soffietti, Riccardo; Del Re, Marzia
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Pharmacogenetics of CYP2D6 and tamoxifen therapy: Light at the end of the tunnel? | 1-gen-2016 | DEL RE, Marzia; Citi, Valentina; Crucitta, Stefania; Rofi, Eleonora; Belcari, Francesca; Van Schaik, R. H.; Danesi, Romano | |
| KRAS mutations as potential mechanism of crizotinib acquired resistance: a study on circulating tumor DNA. | 1-gen-2016 | DEL RE, Marzia; Bordi, Paola; Citi, Valentina; Crucitta, Stefania; Rofi, Eleonora; Petrini, Iacopo; Tiseo, Marcello; Danesi, Romano | |
| Pharmacogenetics and metabolism from science to implementation in clinical practice: the example of dihydropyrimidine dehydrogenase. | 1-gen-2017 | Del Re, M; Restante, G; Di Paolo, A; Crucitta, S; Rofi, E; Danesi, R. | |
| The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients | 1-gen-2017 | DEL RE, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano | |
| The role of drug-drug interactions in prostate cancer treatment: Focus on abiraterone acetate/prednisone and enzalutamide | 1-gen-2017 | DEL RE, Marzia; Fogli, Stefano; Derosa, Lisa; Massari, Francesco; De Souza, Paul; Crucitta, Stefania; Bracarda, Sergio; Santini, Daniele; Danesi, Romano | |
| Reply to Ugo De Giorgi, Vincenza Conteduca, and Emanuela Scarpi's Letter to the Editor re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:680â7 | 1-gen-2018 | Del Re, Marzia; Biasco, Elisa; Crucitta, Stefania; Derosa, Lisa; Rofi, Eleonora; Orlandini, Cinzia; Miccoli, Mario; Galli, Luca; Falcone, Alfredo; Jenster, Guido W.; van Schaik, Ron H.; Danesi, Romano | |
| Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment | 1-gen-2018 | Arrigoni, Elena; Del Re, Marzia; Galimberti, Sara; Restante, Giuliana; Rofi, Eleonora; Crucitta, Stefania; Baratè, Claudia; Petrini, Mario; Danesi, Romano; Di Paolo, Antonello | |
| Concise Review: Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer: The Role of Cancer Stem Cells | 1-gen-2018 | Del Re, Marzia; Arrigoni, Elena; Restante, Giuliana; Passaro, Antonio; Rofi, Eleonora; Crucitta, Stefania; De Marinis, Filippo; Di Paolo, Antonello; Danesi, Romano | |
| PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC | 1-gen-2018 | DEL RE, Marzia; Marconcini, Riccardo; Pasquini, Giulia; Rofi, Eleonora; Vivaldi, Caterina; Bloise, Francesco; Restante, Giuliana; Arrigoni, Elena; Caparello, Chiara; Bianco, MARIA GRAZIA; Crucitta, Stefania; Petrini, Iacopo; Vasile, Enrico; Falcone, Alfredo; Danesi, Romano | |
| EGFR-TKIs in non-small-cell lung cancer: Focus on clinical pharmacology and mechanisms of resistance | 1-gen-2018 | Fogli, Stefano; Polini, Beatrice; DEL RE, Marzia; Petrini, Iacopo; Passaro, Antonio; Crucitta, Stefania; Rofi, Eleonora; Danesi, Romano | |
| Pharmacogenetics of androgen signaling in prostate cancer: focus on castration resistance and predictive biomarkers of response to treatment | 1-gen-2018 | Del Re, Marzia; Crucitta, Stefania; Restante, Giuliana; Rofi, Eleonora; Arrigoni, Elena; Biasco, Elisa; Sbrana, Andrea; Coppi, Erika; Galli, Luca; Bracarda, Sergio; Santini, Daniele; Danesi, Romano | |
| The amount of activating EGFR mutations in circulating cell-free DNA is a marker to monitor osimertinib response | 1-gen-2018 | Del Re, Marzia; Bordi, Paola; Rofi, Eleonora; Restante, Giuliana; Valleggi, Simona; Minari, Roberta; Crucitta, Stefania; Arrigoni, Elena; Chella, Antonio; Morganti, Riccardo; Tiseo, Marcello; Petrini, Iacopo; Danesi, Romano | |
| Overexpression of TK1 and CDK9 in plasma-derived exosomes is associated with clinical resistance to CDK4/6 inhibitors in metastatic breast cancer patients | 1-gen-2019 | Del Re, Marzia; Bertolini, Ilaria; Crucitta, Stefania; Fontanelli, Lorenzo; Rofi, Eleonora; DE ANGELIS, Claudia; Diodati, Lucrezia; Cavallero, Diletta; Gianfilippo, Giulia; Salvadori, Barbara; Fogli, Stefano; Falcone, Alfredo; Scatena, Cristian; Naccarato, Antonio Giuseppe; Roncella, Manuela; Ghilli, Matteo; Morganti, Riccardo; Fontana, Andrea; Danesi, Romano | |
| Understanding the Mechanisms of Resistance in EGFR-Positive NSCLC: From Tissue to Liquid Biopsy to Guide Treatment Strategy | 1-gen-2019 | Del Re, Marzia; Crucitta, Stefania; Gianfilippo, Giulia; Passaro, Antonio; Petrini, Iacopo; Restante, Giuliana; Michelucci, Angela; Fogli, Stefano; de Marinis, Filippo; Porta, Camillo; Chella, Antonio; Danesi, Romano | |
| From the beginning to resistance: study of plasma monitoring and resistance mechanisms in a cohort of patients treated with osimertinib for advanced T790M-positive NSCLC | 1-gen-2019 | Bordi, Paola; Del Re, Marzia; Minari, Roberta; Rofi, Eleonora; Buti, Sebastiano; Restante, Giuliana; Squadrilli, Anna; Crucitta, Stefania; Casartelli, Chiara; Gnetti, Letizia; Azzoni, Cinzia; Bottarelli, Lorena; Petrini, Iacopo; Cosenza, Agnese; Ferri, Leonarda; Rapacchi, Elena; Danesi, Romano; Tiseo, Marcello | |
| Circulating biomarkers of response to immunotherapy in cancer treatment | 1-gen-2019 | Re, M. D.; Gianfilippo, G.; Crucitta, S.; Addeo, A.; Van Schaik, R. H. N.; Danesi, R. | |
| AR-V7 and AR-FL expression is associated with clinical outcome: a translational study in patients with castrate resistant prostate cancer | 1-gen-2019 | Del Re, Marzia; Crucitta, Stefania; Sbrana, Andrea; Rofi, Eleonora; Paolieri, Federico; Gianfilippo, Giulia; Galli, Luca; Falcone, Alfredo; Morganti, Riccardo; Porta, Camillo; Efstathiou, Eleni; van Schaik, Ron; Jenster, Guido; Danesi, Romano | |
| Endothelial nitric oxide synthase c.-813C>T predicts for proteinuria in metastatic breast cancer patients treated with bevacizumab-based chemotherapy | 1-gen-2019 | Crucitta, S.; Restante, G.; Del Re, M.; Bertolini, I.; Bona, E.; Rofi, E.; Fontanelli, L.; Gianfilippo, G.; Fogli, S.; Stasi, I.; Ghilli, M.; Fontana, A.; Danesi, R. | |
| Clinical pharmacology of monoclonal antibodies targeting anti-PD-1 axis in urothelial cancers | 1-gen-2019 | Rofi, E.; Del Re, M.; Arrigoni, E.; Rizzo, M.; Fontanelli, L.; Crucitta, S.; Gianfilippo, G.; Restante, G.; Fogli, S.; Porta, C.; Danesi, R.; Schmidinger, M. | |
| Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring | 1-gen-2019 | Pasqualetti, Francesco; Restante, Giuliana; Gonnelli, Alessandra; Rofi, Eleonora; Molinari, Alessandro; Crucitta, Stefania; Paiar, Fabiola; Rudà, Roberta; Danesi, Romano; Soffietti, Riccardo; Del Re, Marzia |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile